Abstract:Artesunate (ART) has been reported to have an antifibrotic effect in various organs. The underlying mechanism has not been systematically elucidated. We aimed to clarify the effect of ART on liver fibrosis induced by Schistosoma japonicum ( S . japonicum ) in an experimentally infected rodent model and the potential underlying mechanisms. The effect of ART on hepatic stellate cells (HSCs) was assessed using CCK-8 and Annexin V-FITC/PI staining assays. The experimental model of liver fibrosis was established in the Mongolian gerbil model infected with S . japonicum cercariae and then treated with 20 mg/kg or 40 mg/kg ART. The hydroxyproline (Hyp) content, malondialdehyde (MDA) content, superoxide dismutase (SOD) and glutathione peroxidase (GPX) activities in liver tissue were measured and histopathological changes of liver tissues were observed. Whole-transcriptome RNA sequencing (RNA-seq) of the liver tissues was performed. Differentially expressed genes (DEGs) were identified using bioinformatic analysis and verified by quantitative PCR (qPCR) and western blot assay. ART significantly inhibited the proliferation and induce the apoptosis of HSCs in a dose-dependent manner. In vivo , Hyp content decreased significantly in the ART-H group compared to the model (MOD) group and GPX activity was significantly higher in the ART-H group than in the MOD group. Besides, ART treatment significantly reduced collagen production (p <0.05). A total of 158 DEGs and 44 differentially expressed miRNAs related to ART-induced anti-schistosomiasis liver fibrosis were identified. The qPCR and western blot results of selected DEGs were consistent with the sequencing results. These DEGs were implicated in key pathways such as immune and inflammatory response, integrin-mediated signaling and toll-like receptor signaling pathways. ART is effective against liver fibrosis using Mongolian gerbil model induced by S . japonicum infection. We identified host candidate regulators of schistosomiasis-induced liver fibrosis in response to ART through transcriptomics approach. Artesunate (ART) has been reported to have an antifibrotic effect while the underlying mechanism has not been systematically elucidated. Here, we evaluated the effect of ART on anti-hepatic fibrosis in vitro and in vivo. We found that ART significantly inhibited the proliferation and induced the apoptosis of HSCs. And also ART is effective against liver fibrosis using Mongolian gerbil model induced by Schistosoma japonicum ( S . japonicum ) infection. Hyp content decreased significantly in the ART-H group compared to the MOD group and GPX activity was significantly higher in the ART-H group than in the MOD group. Besides, ART treatment significantly reduced collagen production (p<0.05). A total of 158 DEGs and 44 differentially expressed miRNAs related to ART-induced anti-schistosomiasis liver fibrosis were identified through transcriptomics approach. These DEGs were implicated in key pathways such as immune and inflammatory response, integrin-mediated signaling and toll-like receptor signaling pathways. Our findings suggest that ART is effective against liver fibrosis. Furthermore, we identified 30 host candidate regulators in response to ART, and provides a basis for a better understanding of the molecular mechanisms of ART on anti-hepatic fibrosis.

Dissecting the dilemma between<i>in vitro</i>and<i>in vivo</i>drug screening: treating HepG2 cells with Artesunate as a model

Artesunate pErk up HepG2 cells to die through apoptosis in vitro

Dependence of Artesunate on Long Noncoding RNA‐RP11 to Inhibit Epithelial‐mesenchymal Transition of Hepatocellular Carcinoma

Preclinical Investigation of Artesunate As a Therapeutic Agent for Hepatocellular Carcinoma Via Impairment of Glucosylceramidase-Mediated Autophagic Degradation.

Experimental Therapy Of Hepatoma With Artemisinin And Its Derivatives: In Vitro And In Vivo Activity, Chemosensitization, And Mechanisms Of Action

[Anticancer Effect of SN-38 Combined with Sorafenib on Hepatocellular Carcinoma in Vitro and Its Mechanism].

Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells

Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.

Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells

Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro.

Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy

Artemisinin Suppresses Hepatocellular Carcinoma Cell Growth, Migration and Invasion by Targeting Cellular Bioenergetics and Hippo-YAP Signaling

Inhibiting Effect of Different Administration Route of Gemcitabine Combined with Cisplatin on A549 Cell Lines

Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells

The Synergistic Anticancer Effect of Artesunate Combined with Allicin in Osteosarcoma Cell Line in Vitro and in Vivo

Anti-liver cancer effect and the mechanism of arsenic sulfide in vitro and in vivo

Mining host candidate regulators of schistosomiasis-induced liver fibrosis in response to artesunate therapy through transcriptomics approach

Down-regulating Effect of Artesunate on T Lymphocytes ’ Immunosuppression in Human Laryngocarcinoma Cells in Vitro

Relationships Among Serological Indicators and In Vitro High-Throughput Drug Sensitivity Screening Results in Patients with Hepatocellular Carcinoma

Integrating network pharmacology, molecular docking and experimental verification to reveal the mechanism of artesunate in inhibiting choroidal melanoma

Inhibitory Effects of Artesunate on Angiogenesis in Chick Chorioallantoic Membrane